HB2081

Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program

Introduced·1/7/26
Introduced Text

HB2081 establishes reporting requirements for entities participating in the 340B drug pricing program in Missouri.

HB2081 creates provisions for entities participating in the 340B drug pricing program to report specific data annually. These entities must report information such as the number of prescription drugs dispensed, aggregate acquisition costs, and payments made to pharmacies. The data must be submitted to the Department of Health and Senior Services by April 1 each year. The department then aggregates the data and submits a report to the general assembly and posts it on its website by November 15. Entities failing to report by the required date face a fine of $1,000 per day.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Emerging Issues Committee
Next
Committee decision

Sponsors

0
2
RR
Democratic CaucusRepublican Caucus

History

May 15

House

Referred: Emerging Issues(H)

Jan 8

House

Read Second Time (H)

Jan 7

House

Read First Time (H)